Back to Search Start Over

Assessment of Promising Protein Markers for Vulva Cancer

Authors :
Jacobus van der Velden
Matthé P.M. Burger
Guus Fons
Fiebo J.W. ten Kate
Obstetrics and Gynaecology
Other Research
Amsterdam Gastroenterology Endocrinology Metabolism
Cancer Center Amsterdam
Pathology
Source :
International journal of gynecological cancer, 19(4), 756-760. Wolters Kluwer Health
Publication Year :
2009

Abstract

Objectives: To validate the results of a previous study with the tissue microarray technology showing that cyclooxygenase 2 (COX-2) overexpression and absent caspase 3 expression are associated with poor disease-specific survival in univariate analysis. Methods: The study group comprised 80 consecutive patients with vulva cancer treated in the period from 1999 to 2003 in a university hospital. A tissue microarray with 3 tumor tissue cores per patient was constructed and stained with antibodies against COX-2, caspase 3, epidermal growth factor receptor, p16(INK4), cyclin D1, and Ki-67. The impact of the expression of these protein markers and selected clinicopathologic variables on disease-specific as well as disease-free survival was measured. Cox proportional hazard model was used for both univariate and multivariate analyses. Results: In multivariate analysis, lymph node metastases and strong COX-2 expression were related to disease-free (hazard ratio [HR], 8.33, 95% confidence interval [CI], 2.97-23.36; P

Details

Language :
English
ISSN :
1048891X
Database :
OpenAIRE
Journal :
International journal of gynecological cancer, 19(4), 756-760. Wolters Kluwer Health
Accession number :
edsair.doi.dedup.....cdc2133badfc851f141697cb1c603bbd